MARX Biotech Co., Ltd. (7731) Stock Statistics & Valuation Metrics
Total Valuation
MARX Biotech Co., Ltd. has a market cap or net worth of TWD 2.18B. The enterprise value is ―.
- Market Cap
- TWD 2.18B
- Enterprise Value
- ―
Share Statistics
MARX Biotech Co., Ltd. has 539,980,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 539,980,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
MARX Biotech Co., Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is -15.23%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- -15.23%
- Return on Capital Employed (ROCE)
- -0.27
- Revenue Per Employee
- 7.95M
- Profits Per Employee
- 536.52K
- Employee Count
- 80
- Asset Turnover
- 0.76
- Inventory Turnover
- 2.18
Valuation Ratios
The current PE Ratio of MARX Biotech Co., Ltd. is 43.73. MARX Biotech Co., Ltd.’s PEG ratio is 0.16.
- PE Ratio
- 43.73
- PS Ratio
- 2.65
- PB Ratio
- 8.10
- Price to FCF
- -10.76
- Price to Operating Cash Flow
- -11.11
- PEG Ratio
- 0.16
Income Statement
In the last 12 months, MARX Biotech Co., Ltd. had revenue of 635.85M and earned 42.92M in profits. Earnings per share was 0.09.
- Revenue
- 635.85M
- Gross Profit
- 394.59M
- Operating Income
- -139.46M
- Pretax Income
- 57.78M
- Net Income
- 42.92M
- EBITDA
- 91.00M
- Earnings Per Share (EPS)
- 0.09
Cash Flow
In the last 12 months, operating cash flow was -210.42M and capital expenditures -5.38M, giving a free cash flow of -215.80M billion.
- Operating Cash Flow
- -210.42M
- Free Cash Flow
- -215.80M
- Free Cash Flow per Share
- -0.40
Dividends & Yields
MARX Biotech Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.42%
- Dividend Per Share
- ―
- Dividend Yield
- 1.42%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.77%
- Earnings Yield
- 2.16%
Stock Price Statistics
- Beta
- 0.34
- 52-Week Price Change
- -16.20%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 41.97
- Average Volume (3m)
- 871.34K
Financial Position
MARX Biotech Co., Ltd. as a current ratio of 1.78, with Debt / Equity ratio of 85.64%
- Current Ratio
- 1.78
- Quick Ratio
- 1.42
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 3.02
- Interest Coverage Ratio
- -10.19
Taxes
In the past 12 months, MARX Biotech Co., Ltd. has paid 15.60M in taxes.
- Income Tax
- 15.60M
- Effective Tax Rate
- 0.27
Enterprise Valuation
MARX Biotech Co., Ltd. EV to EBITDA ratio is -11.32, with an EV/FCF ratio of -10.91.
- EV to Sales
- 2.69
- EV to EBITDA
- -11.32
- EV to Free Cash Flow
- -10.91
- EV to Operating Cash Flow
- -11.19
Balance Sheet
MARX Biotech Co., Ltd. has TWD 73.31M in cash and marketable securities with TWD 219.99M in debt, giving a net cash position of -TWD 146.68M billion.
- Cash & Marketable Securities
- TWD 73.31M
- Total Debt
- TWD 219.99M
- Net Cash
- -TWD 146.68M
- Net Cash Per Share
- -TWD 0.27
- Tangible Book Value Per Share
- TWD 0.41
Margins
Gross margin is 50.21%, with operating margin of -26.12%, and net profit margin of 5.47%.
- Gross Margin
- 50.21%
- Operating Margin
- -26.12%
- Pretax Margin
- 5.00%
- Net Profit Margin
- 5.47%
- EBITDA Margin
- -23.71%
- EBIT Margin
- -26.12%
Analyst Forecast
The average price target for MARX Biotech Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -17.97%
- EPS Growth Forecast
- ―
